Acknowledgement

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777365. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

Twitter

Latest News

Contact








Newsletter